newsfilter
← Latest News
Business Wire·

Long-Term Data From the MIRROR Randomized Controlled Trial of KRYSTEXXA® (pegloticase) Injection With Methotrexate Published in ACR Open Rheumatology

-- Month 12 data reinforce durable efficacy of co-treatment approach -- Horizon Therapeutics plc (NASDAQ:HZNP) today announced the publication of the long-term data from the MIRROR randomized controlled clinical trial